Skip to main content
SpringerLink
Log in

Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Introduction: Recent evidence suggests that magnesium may be neuroprotective in the setting of cerebral ischemia, and therapeutic magnesium infusion has been proposed for prophylaxis and treatment of delayed ischemic neurological deficit (DIND) resulting from vasospasm in patients with aneurysmal subarachnoid hemorrhage (SAH). We studied the association between serum magnesium levels, the development of DIND, and the outcomes of patients with SAH.

Methods: We studied 128 consecutive patients with aneurysmal SAH treated at our institution between 1990 and 1997 who had a serum magnesium level measured at least once during the acute phase of their hospitalization. Delayed ischemic neurological deficit was defined as severe (major focal deficit or coma), moderate (incomplete focal deficit or decreased sensorium without coma), or none.

Results: There was no significant difference in mean, minimum, or maximum serum magnesium levels between patients with and without DIND (1.93, 1.83, 2.02 versus 1.91, 1.84, 1.97 mg/dL, respectively). Similarly, no difference was found in mean serum magnesium levels among patients with severe (1.94 mg/dL), moderate (1.92 mg/dL), or no DIND (1.91 mg/dL). Analyses of serum magnesium levels before (0–4 days following SAH), during (4–14 days following SAH), and after (greater than 14 days following SAH) the period of highest risk for vasospasm revealed no association with the development or severity of DIND. Permanent deficit or death resulting from vasospasm and Glasgow Outcome Scale score at longest follow-up were similarly unaffected by serum magnesium levels overall or during any time interval. Forty (31.5%) patients were hypomagnesemic (less than 1.7 mg/dL) during hospitalization, but no difference in outcome (p=0.185) or development of DIND (p=0.785) was found when compared to patients with normal (1.7–2.1 mg/dL) or high (greater than 2.1 mg/dL) magnesium serum levels.

Conclusion: We identified no relationship between serum magnesium levels and the development of DIND or outcome following aneurysmal SAH. Based on these data, magnesium supplementation to normal or high-normal physiological ranges seems unlikely to be beneficial for DIND resulting from vasospasm. However, no inference can be made regarding the value of therapeutic infusion of magnesium to supraphysiological levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kassell NF, Sasaki T, Colohan ART, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562–572.

    PubMed  CAS  Google Scholar 

  2. Macdonald RL, Weir B. Cerebral vasospasm: prevention and treatment. In: Cerebrovascular disease. (Batjer H, ed.). Lippincott-Raven, Philadelphia, 1997, 1111–1121.

    Google Scholar 

  3. Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983;308:619–624.

    Article  PubMed  CAS  Google Scholar 

  4. Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR. Cerebral arterial spasm, a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983;308:619–624.

    Article  PubMed  Google Scholar 

  5. Elliott JP, Newell DW, Lam DJ, et al. Comparaison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998;88:277–284.

    PubMed  CAS  Google Scholar 

  6. Haley ECH, Kassel NF, Torner JC. The international cooperative study on the timing of aneurysm surgery: the North American experience. Stroke 1992;23:205–214.

    PubMed  Google Scholar 

  7. Haley ECH, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg 1993;78:537–547.

    PubMed  Google Scholar 

  8. Takaku A, Tamaka S, Mori T, Susuki J. Postoperative complications in 1000 cases of intracranial anevrysms. Surg Neurol 1979;12:137–144.

    PubMed  CAS  Google Scholar 

  9. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M. Magnesium sulphate reverses experimental delayed cerebral vasospasm after SAH in rats. Stroke 1991; 22:922–927.

    PubMed  CAS  Google Scholar 

  10. Altura BM, Altura BT. Magnesium and contraction of arterial smooth muscle. Microvasc Res 1974;7:145–155.

    Article  PubMed  CAS  Google Scholar 

  11. Altura BT, Altura BM. Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of vascular tone in cerebral arteries. Neurosci Lett 1980;20:323–327.

    Article  PubMed  CAS  Google Scholar 

  12. Altura BM, Altura BT. Magnesium and contraction of vascular smooth muscles: Relationship to some vascular diseases. Fed Proc 1981;40:2672–2679.

    PubMed  CAS  Google Scholar 

  13. Altura BT, Altura BM. The role of magnesium in etiology of strokes and cerebrovasospasm. Magnesium 1982;1:277–291.

    Google Scholar 

  14. Ema M, Gebrewold A, Altura BT, Altura BM. Magnesium sulfate prevents alcohol-induced spasms of cerebral blood vessels: an in situ study on the brain microcirculation from male versus female rats. Magnes Trace Elem 1991;10:269–280.

    PubMed  CAS  Google Scholar 

  15. Iseri LT, French JH. Magnesium: nature’s physiologic calcium blocker. Am Heart J 1984;108:188–193.

    Article  PubMed  CAS  Google Scholar 

  16. Vink R, Mc Intosh TK. Pharmacological and physiological effects of magnesium on experimental traumatic brain injury. Magnes Res 1990;3:163–169.

    PubMed  CAS  Google Scholar 

  17. Vink R, McIntosh TK, Romhanyi R, Faden AI. Opiate antagonist nalfemene improves intracellular free magnesium bioenergetic state and neurological outcome following traumatic brain injury in rats. J Neurosci. 1990;10:3524–3530.

    PubMed  CAS  Google Scholar 

  18. Farber JL, Chien KR. The pathogenesis of irreversible cell injury in ischemia. Am J Pathol 1981;102:271–281.

    PubMed  CAS  Google Scholar 

  19. Izumi Y, Roussel S, Pinard E, Seylaz J. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1991;11:1025–1030.

    PubMed  CAS  Google Scholar 

  20. Kass IS, Cottrel JE, Chambers G. Magnesium and cobalt, not nimodipine protect neurons against anoxic damage in the rat hippocampal slice. Anesthesiology 1988;69:710–715.

    Article  PubMed  CAS  Google Scholar 

  21. Marinov M, Harbaugh KS, Hoopes PJ, Pikus HJ, Harbaugh RE. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996;85:117–124.

    PubMed  CAS  Google Scholar 

  22. McIntosh TK, Vink R, Yamakami I, Faden AI. Magnesium protects against neurological deficit after brain injury. Brain Res 1989;482:252–260.

    Article  PubMed  CAS  Google Scholar 

  23. Rehncrona S, Westerberg E, Akesson B, Siesjo BJ. Brain cortical fatty acids and phospholipids during and following complete and severe incomplete ischemia. J Neurochem 1982;38:84–93.

    Article  PubMed  CAS  Google Scholar 

  24. Vacanti FX, Ames A III. Mild hypothermia and magnesium protect against irreversible damage during CNS ischemia. Stroke 1984;15:695–698.

    PubMed  CAS  Google Scholar 

  25. Woodruff GN, Foster AC, Gill R, Kemp JA, Wong EH, Iversen LL. The interaction between MK-801 and receptors for N-methyl-d-aspartate: functional consequences. Neuropharmacology 1987;26:903–909.

    Article  PubMed  CAS  Google Scholar 

  26. Cheung JY, Bonventre JV, Malis CD, Leaf A. Calcium and ischemic injury. N Engl J Med 1986;314:1670–1676.

    Article  PubMed  CAS  Google Scholar 

  27. Goldman RS, Finkbeiner SM. Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure. N Engl J Med 1988; 319:1224–1225.

    Article  PubMed  CAS  Google Scholar 

  28. Mayer ML, Westerbrook GL, Guthrie PB. Voltage-dependent block by magnesium of NMDA responses in spinal cord neurones. Nature (Letter) 1984;309:261–263.

    Article  CAS  Google Scholar 

  29. Meldrum BS, Evans MC, Swan JH, Simon RP. Protection against hypoxic/ischemic brain damage with excitatory amino acid antagonists. Med Biol (review) 1987;65:153–157.

    CAS  Google Scholar 

  30. Nowak L, Bregestovski P, Ascher P. Magnesium gates glutamate-acivated channels in mouse central neurones. Nature (Letter) 1984;307:462–465.

    Article  CAS  Google Scholar 

  31. Priestley T, Horne AL, Mc Kernan RM, Kemp JA. The effect of NMDA receptor glycine site antagonist on hypoxia-induced neurodegeneration of rat cortical cell culture. Brain Res 1990;531:183–188.

    Article  PubMed  CAS  Google Scholar 

  32. Rothman S. Synaptic activity mediates death of hypoxic neurones. Science 1983;220:536–537.

    Article  PubMed  CAS  Google Scholar 

  33. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor. Trends Neurol Sci 1987;10:299–302.

    Article  CAS  Google Scholar 

  34. Anthony J, Johanson R, Dommisse J. Critical Care Management of severe pre-eclampsia. Fet Mat Med Rev 1994;6:219–229.

    Google Scholar 

  35. Anthony J, Johanson RB, Duley L. Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia. Drug Safety 1996;15:188–199.

    PubMed  CAS  Google Scholar 

  36. McLean RM. Magnesium and its therapeutic uses: a review. Am J Med 1994;96:63–76.

    Article  PubMed  CAS  Google Scholar 

  37. Pritchard JA, Pritchard SA. Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol 1975;123:543–552.

    PubMed  CAS  Google Scholar 

  38. Sabai GM, Anderson GD. Eclampsia. In: Neurological disorder of pregnancy. (Goldstein P, ed.). Futura Publishing, Mount Kisco, 1986, 1–18.

    Google Scholar 

  39. Sadeh M. Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. Stroke 1989;20:1273–1275.

    PubMed  CAS  Google Scholar 

  40. Watson KV, Moldow CF, Ogburn PL, Jacob HS. Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci USA 1986;83:1075–1078.

    Article  PubMed  CAS  Google Scholar 

  41. Evans S, Frigoletto F, Jewett JF. Mortality of eclampsia; a case report and the experience of the Massachusetts maternal mortality study, 1954–1982. N Engl J Med 1984;309:1644–1647.

    Article  Google Scholar 

  42. Will AD, Lewis KL, Hinshaw DB, et al. Cerebral vasoconstriction in toxemia. Neurology 1987;37:1555–1557.

    PubMed  CAS  Google Scholar 

  43. Lewis KL, Hinshaw DB, Will AD, Hasso AN, Thompson JR. CT and angiographic correlations of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988;30:59–64.

    Article  PubMed  CAS  Google Scholar 

  44. Beck RW, Menezes AH. Intracerebral hemorrage in a patient with eclampsia. JAMA 1981;246:1442–1443.

    Article  PubMed  CAS  Google Scholar 

  45. Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988;19:326–329.

    PubMed  CAS  Google Scholar 

  46. Belfort MA, Moise KJ. Effect on magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992;167:661–666.

    PubMed  CAS  Google Scholar 

  47. Boet R, Mee E. Magnesium Sulfate in the management of patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 2000;47:602–607.

    Article  PubMed  CAS  Google Scholar 

  48. Veyna RS, Seyfried D, Burke D, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002;96:510–514.

    PubMed  CAS  Google Scholar 

  49. Ryzen E, Wagers PW, Singer FR, Rude RK. Magnesium deficiency in a medical ICU population. Crit Care Med 1985;13:19–21.

    Article  PubMed  CAS  Google Scholar 

  50. Memon ZI, Altura BT, Benjamin JL, Cracco RQ, Altura BM. Predictive value of serum ionized but not total magnesium levels in head injurie. Scand J Clin Lab Invest 1995;55:671–677.

    PubMed  CAS  Google Scholar 

  51. Altura BT, Memon Z, Zhang A, et al. Low levels of serum ionized magnesium found in stroke patients result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular muscle cells. Neurosci Lett 1997;230:37–40.

    Article  PubMed  CAS  Google Scholar 

  52. Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med 1979;300:1142–1147.

    Article  PubMed  CAS  Google Scholar 

  53. Vink R, McIntosh TK, Demediuk P, Weiner W, Faden AI. Decline in intracellular free magnesium concentration is associated with irreversible tissue injury following brain trauma. J Biol Chem 1988;263:757–761.

    PubMed  CAS  Google Scholar 

  54. McIntosh TK, Smith DH, Meaney DF, Kotapka MJ, Gennarelli TA, Graham DI. Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biochemical mechanism. Lab Invest 1996;74:315–342.

    PubMed  CAS  Google Scholar 

  55. Williams GD, Smith MB. Application of the accurate assessment of intracellular magnesium and pH from the P-31 shifts of ATP to cerebral hypoxia-ischemia in neonatal rat. Magn Reson Med 1995;33:853–857.

    Article  PubMed  CAS  Google Scholar 

  56. Helpern JA, Van De Linde AMQ, Welch. KMA, et al. Acute elevation and recovery of intracellular magnesium following human focal cerebral ischemia. Neurology 1993;43:1577–1581.

    PubMed  CAS  Google Scholar 

  57. Mullins PGM, Vink R. Chronic alcohol exposure decreases brain intracellular free magnesium concentration in rats. Neuroreport 1995;6:1633–1636.

    Article  PubMed  CAS  Google Scholar 

  58. Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and stroke as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR spectroscopy, and a unique magnesium ion-selective electrode. Alcohol Clin Exp Res 1994;18:1057–1068.

    Article  PubMed  CAS  Google Scholar 

  59. Altura BM, Gupta RK. Cocaine induces intracellular free magnesium deficits, ischemia and stroke as observed by in-vivo 31P NMR of the brain. Biochim Biophys Acta 1992;1111:271–274.

    Article  PubMed  CAS  Google Scholar 

  60. Feldman Z, Gurevitch B, Artru AA, Oppenheim A, Shohami E, Reichenthal E, Shapira Y. Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. J Neurosurg 1996;85:131–137.

    Article  PubMed  CAS  Google Scholar 

  61. Vink R, Heath DL, McIntosh TK. Acute and prolonged alterations in brain free magnesium following fluid percussion-induced brain trauma in rats. J Neurochem 1996;66:2477–2483.

    Article  PubMed  CAS  Google Scholar 

  62. McIntosh TK, Faden AI, Yamakami I, Vink R. Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies. J Neurotrauma 1988;5:17–31.

    Article  PubMed  CAS  Google Scholar 

  63. Ewlin RJ. Magnesium metabolism in health and disease. Dis Month 1988;34:165–218.

    Google Scholar 

  64. Oppelt WW, Macintyre I, Rall DP. Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol 1963;205:959–962.

    PubMed  CAS  Google Scholar 

  65. Bito L. Blood brain barrier, evidence for acute cation transport between blood and the extracellular fluid of brain. Science 1969;165:81–83.

    Article  CAS  PubMed  Google Scholar 

  66. Gee JB, Corbett RJT, Perlman JM, Laptook AR. Hypermagnesemia does not increase brain intracellular magnesium in newborn swine. Pediatr Neurol 2001;25:304–308.

    Article  PubMed  Google Scholar 

  67. Brewer RP, Parra A, Borel CO, Hopkins MB, Reynolds JD. Intravenous magnesium sulfate does not increase ventricular CSF ionized magnesium concentration of patients with intracranial hypertension. Clin Neuropharmacol 2001;24:341–345.

    Article  PubMed  CAS  Google Scholar 

  68. Hallak M, Berman RF, Irtenkauf SM, Evans MI, Cotton DB. Peripheral magnesium sulfate enters the brain and increases the treshold for hippocampal seizure in rats. Am J Obstet Gynecol 1992;167:1605–1610.

    PubMed  CAS  Google Scholar 

  69. Kim YJ, Mc Farlane C, Warner DS, Baker MT, Choi WW, Dexter F. The effect of plasma and brain magnesium concentration on lidocaine-induced seizure in rats. Anesth Analg 1996;83: 1223–1228.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota

    Frederic P. Collignon, David G. Piepgras, Mark A. Pichelmann, Jon I. McIver & L. Gerard Toussaint III

  2. Department of Biostatistics, Mayo Clinic, Rochester, Minnesota

    Robyn L. McClelland

  3. Section of Neurosurgery, Dartmouth Hitchcock Medical Center, One Medical Center Drive, 03766, Lebanon, NH

    Jonathan A. Friedman MD

Authors
  1. Frederic P. Collignon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan A. Friedman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David G. Piepgras
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark A. Pichelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jon I. McIver
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Gerard Toussaint III
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robyn L. McClelland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan A. Friedman MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collignon, F.P., Friedman, J.A., Piepgras, D.G. et al. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Neurocrit Care 1, 441–448 (2004). https://doi.org/10.1385/NCC:1:4:441

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/NCC:1:4:441

Key Words

Search

Navigation